Real-time enrollment status for this myelodysplastic syndromes clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 1:54 AM UTC
| NCT Number | NCT03886662 |
| Recruiting Status | Recruiting |
| Condition | Myelodysplastic Syndromes |
| Phase | PHASE1 |
| Target Enrollment | 47 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Lixte Biotechnology Holdings, Inc. |
| Last Updated on CT.gov | April 8, 2019 (Apr 8, 2019) |
As of July 21, 2026: Clinical trial NCT03886662 is currently recruiting participants. This phase1 study for myelodysplastic syndromes is actively seeking new participants at 1 location across the United States. The study is sponsored by Lixte Biotechnology Holdings, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03886662 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03886662 was last updated Apr 8, 2019 (April 8, 2019). HelloStudys verifies this status automatically.